Loading company…
Neurescue Aps makes a fluoroscopy-free aortic balloon catheter for treating cardiac arrest, based in Copenhagen, Denmark.
Neurescue Aps develops a medical device for treating cardiac arrest, which the input describes as the leading cause of death worldwide. Its Neurescue device is an aortic balloon catheter that is inflated in the descending aorta through a femoral artery introducer sheath, without fluoroscopy. Founded in 2014 by CEO Habib Frost and Bjorn Broby Glavind and based in Copenhagen, Denmark, the company raised DKK 50 million in a Series A round led by West Hill Capital in February 2024, and also raised venture funding from Nina Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in